Latest Oncology News

Understanding Recent Developments in Mantle Cell Lymphoma

November 23, 2022

In an interview with Targeted Oncology, Jia Ruan, MD, PhD, discussed the updates in the mantle cell lymphoma space, including understanding molecular pathogenesis and risk stratification for this patient population.

Efebera Discusses Different Regimens for Transplant-Eligible NDMM

November 23, 2022

During a Targeted Oncology case-based roundtable event, Yvonne A. Efebara, MD, MPH, discussed the role of triplet and quadruplet systemic therapies for newly diagnosed multiple myeloma and the use of autologous stem cell transplant.

CD19-/CD22-CAR T Cells Elicits Durable Remissions in Children With R/R B-Cell ALL

November 22, 2022

In pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia, complete remissions were achieved in 99.0% of patients and their overall 12-month event-free survival was 73.5% with CD19-/CD22-chimeric antigen receptor therapy.